Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

American Journal of Psychiatry

Volumn 157, Issue 11, 2000, Pages 1835-1842

  George, T R ^a   Ziedonis, D M ^a   Feingold, A ^a   Pepper, W T ^a   Satterburg, C A ^a   Winkel, J ^a   Rounsaville, B J ^a   Kosten, T R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; RISPERIDONE;

ABSTINENCE; ADULT; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; GROUP THERAPY; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; SCHIZOPHRENIA; SMOKING CESSATION; SOCIAL ADAPTATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIPSYCHOTIC AGENTS; COMORBIDITY; FEMALE; HUMANS; MALE; NICOTINE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0033755585     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.11.1835     Document Type: Article

References (47)

1. Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues
2. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
3. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland
4. Readiness to stop smoking in schizophrenia
5. Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based treatment model
6. Stages and processes of selfchange of smoking: Toward an integrative model of change
7. Schizophrenia: A life-shortening disease
8. The incidence of cancer in schizophrenic patients
9. Smoking cessation treatment for patients with schizophrenia
10. Clozapine decreases smoking in patients with chronic schizophrenia
11. Effects of clozapine on smoking in chronic schizophrenia outpatients
12. Smoking and therapeutic response to clozapine in patients with schizophrenia
13. Haloperidol increases smoking in patients with schizophrenia
14. Bupropion and smoking cessation (letter)
15. Pharmacotherapy for smoking cessation in schizophrenia: Biological correlates
16. Treatment of nicotine dependence in the chronic mentally ill
17. Group treatment for smoking cessation among persons with schizophrenia
18. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients
19. Contingency management for tobacco smoking in methadone-maintained opiate addicts
20. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
21. An inventory for measuring depression
22. Smoking withdrawal symptoms in two weeks of abstinence
23. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with 'on-off' phenomena
24. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire
25. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: A feasibility study
26. An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics
27. Prospective evaluation of three smoking interventions in 205 recovering alcoholics: One-year results of Project SCRAP-Tobacco
28. Survival probabilities (the Kaplan-Meier method)
29. Application of hierarchical linear models to assessing change
30. Some conceptual and statistical issues in analyses of longitudinal psychiatric data
31. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
32. Decreased substance use in chronically psychotic patients treated with clozapine (letter)
33. Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy
34. The neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications
35. Gating of auditory P50 in schizophrenics: Unique effects of clozapine
36. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers
37. Effects of repeated nicotine pretreatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress
38. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms
39. Subjective experience and mental side-effects of antipsychotic treatment
40. Treatment of neuroleptic-induced akathisia with nicotine patches
41. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia